Plasma Amyloid-Beta Levels in Patients with Different Types of Cancer

@article{Jin2016PlasmaAL,
  title={Plasma Amyloid-Beta Levels in Patients with Different Types of Cancer},
  author={Wang-Sheng Jin and Xian-Le Bu and Yu-Hui Liu and Lin-Lin Shen and Zhen-Qian Zhuang and Shu-Sheng Jiao and Chi Zhu and Qing-hua Wang and Huadong Zhou and Tao Zhang and Yanjiang Wang},
  journal={Neurotoxicity Research},
  year={2016},
  volume={31},
  pages={283-288}
}
Several epidemiological investigations indicate that cancer survivors have a lower risk for Alzheimer’s disease (AD) and vice versa. However, the associations between plasma amyloid-beta (Aβ) levels with cancer remain largely unknown. In this case–control study, 110 cancer patients, 70 AD patients, and 70 age- and gender-matched normal controls were recruited. The cancer types include esophagus cancer, colorectal cancer, hepatic cancer, and lung cancer, all of which were reported to be… 
Higher Plasma Amyloid-β Levels Are Associated with a Higher Risk of Cancer: A Population-Based Prospective Cohort Study
TLDR
It is found that higher levels of both plasma Aβ40 and Aβ42 were associated with a higher risk of cancer, suggesting a potential biological link between Alzheimer disease and cancer.
Accumulation of amyloid beta (Aβ) and amyloid precursor protein (APP) in tumors formed by a mouse xenograft model of inflammatory breast cancer
TLDR
Aβ in inflammatory breast cancer tumors, at least in a mouse model, is always present and is concentrated near blood vessels, and the possible pathways of Aβ accumulation in tumors are discussed.
On the Role of Platelet-Generated Amyloid Beta Peptides in Certain Amyloidosis Health Complications
TLDR
The literature suggesting that there is a similarity between the antimicrobials released by other blood cells and the amyloid-related Aβ peptide released by platelets is reviewed, and it is proposed that platelet-generated Aβ amyloidsosis may be more common than currently recognized.
Amyloid β oligomers inhibit growth of human cancer cells
TLDR
The effect on the cancer cell proliferation rate is less specific to the biological processes developing inside the cells during the proliferation, and cell growth inhibition may involve interactions with the peripheral parts of the cancer cells, such as a phospholipid membrane.
Accumulation of amyloid beta in human glioblastomas
TLDR
It is reported that amyloid build‐up in glioma tumors is a part of the tumor environment, and may be used as a target for developing a novel class of anti‐tumor drugs and as an antigen forglioma visualization.
The Role of Vitamin D and Sunlight Incidence in Cancer.
TLDR
The literature suggests that VD deficiency might be involved in cancer progression, and according to sunlight data, countries with low average sunlight have high cancers death rate.
Accumulation of Innate Amyloid Beta Peptide in Glioblastoma Tumors
TLDR
The presence of aggregated amyloid in glioma tumors together with the presence of Aβ immunofluorescence coinciding withglioma cells and the nearby vasculature imply that the source of A β peptides in gl ioma can be systemic Aβ from blood vessels, but this question remains unresolved and needs additional studies.
Stromal-driven and Amyloid β-dependent induction of neutrophil extracellular traps modulates tumor growth
TLDR
It is reported that CAFs drive NETosis to support cancer progression, identifying Amyloid β as the protagonist and potential therapeutic target.
Diagnostic Utility of Selected Serum Dementia Biomarkers: Amyloid β-40, Amyloid β-42, Tau Protein, and YKL-40: A Review
TLDR
T-t Tau, t-tau/Aβ42, and YKL-40 seem to be promising candidates as biomarkers of cognitive disorders in serum as well as inadequate amyloid marker test repeatability, which may result from imperfection of the used laboratorial techniques or inadequate selection of control groups with their comorbidities.
Cancer Patients Have an Increased Incidence of Dementia: A Retrospective Cohort Study of 185,736 Outpatients in Germany
TLDR
The data provide strong evidence for an increased incidence of dementia in a large cohort of patients with different cancer entities, which should raise awareness of this important comorbidity in cancer patients.
...
...

References

SHOWING 1-10 OF 41 REFERENCES
High sensitivity to carcinogens in the brain of a mouse model of Alzheimer's disease
TLDR
Elevated expression of a mutated form of p53 was found in older AD mice, suggesting an alternative mechanism for the predisposition of AD brains to develop brain tumors, and chronic inflammation promotes cancer.
Why cancer survivors have a lower risk of Alzheimer disease.
  • F. Thinnes
  • Biology
    Molecular genetics and metabolism
  • 2012
Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer’s disease
TLDR
The present work suggests that peripheral Aβ clearance is a valid therapeutic approach for AD, and implies that deficits in the A β clearance in the periphery might also contribute to AD pathogenesis.
IFN-γ and TNF-α are involved during Alzheimer disease progression and correlate with nitric oxide production: a study in Algerian patients.
  • M. Belkhelfa, H. Rafa, C. Touil-Boukoffa
  • Biology
    Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
  • 2014
TLDR
The data indicate that the proinflammatory cytokine production seems, in part, to be involved in neurological deleterious effects observed during the development of AD through NO pathway.
A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines
TLDR
It has been observed in epidemiological studies that treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) decreases the risk for developing AD, and Supplementation of these natural compounds may provide a new therapeutic line of approach to this brain disorder.
Brain to Plasma Amyloid-β Efflux: a Measure of Brain Amyloid Burden in a Mouse Model of Alzheimer's Disease
TLDR
Plasma Aβ levels in a transgenic mouse model of Alzheimer's disease did not correlate with brain amyloid burden, but after peripheral administration of a monoclonal antibody to Aβ, there was a rapid increase in plasma Aβ and the magnitude of this increase was highly correlated with amyloids burden in the hippocampus and cortex.
Pin1: a new genetic link between Alzheimer's disease, cancer and aging.
TLDR
The role of Pin1 in cancer and neurodegeneration is reviewed, the relationship between Pin1 and aging is discussed, its potential as a diagnostic and therapeutic target is explored, and an inverse relationship between Alzheimer's disease and cancer is hypothesized.
Amyloid β-protein deposition in tissues other than brain in Alzheimer's disease
TLDR
The detection of amyloid β-protein deposits in non-neural tissues and blood vessels of Alzheimer's disease patients, including skin, subcutaneous tissue and intestine is reported, indicating that a principal feature of the disease process is expressed subclinically in tissues other than brain.
...
...